Gary S Jacob's Net Worth
-$710 Thousand
Who is Gary S Jacob?
Gary S Jacob does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Synergy Pharmaceuticals, Inc., Virpax Pharmaceuticals, Inc., Hepion Pharmaceuticals, Inc., TrovaGene Inc., OKYO Pharma Ltd, and CALLISTO PHARMACEUTICALS INC.
SEC CIK
Gary S Jacob's CIK is 0001266802
Past Insider Trading and Trends
2013 was Gary S Jacob's most active year for acquiring shares with 16 total transactions. Gary S Jacob's most active month to acquire stocks was the month of December. 2013 was Gary S Jacob's most active year for disposing of shares, totalling 8 transactions. Gary S Jacob's most active month to dispose stocks was the month of December. 2018 saw Gary S Jacob paying a total of $8,877,480.50 for 1,504,590 shares, this is the most they've acquired in one year. In 2017 Gary S Jacob cashed out on 909,287 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Synergy Pharmaceuticals, Inc. No price found
Executive ChairmanGary S Jacob owns 595,460 units of Common Stock. In the year 2011 Gary S Jacob filed a total of 20 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +47.87% | 192.78K |
$0.50 | $237,480.50 | 595.46K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
| +1.43% | 5.68K |
$3.52 | $19,967.47 | 402.68K |
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
| +18.85% | 62.97K |
$5.61 | $353,233.65 | 397K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +1.20% | 4K |
$4.18 | $16,720.00 | 338.03K |
May 27
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4/A
| +9.19% | 26.49K |
—
|
—
| 314.79K |
Jan 17
| |||
Form 4
| -7.76% | -26.49K |
—
|
—
| 314.79K |
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Virpax Pharmaceuticals, Inc. (VRPX) Snapshot price: $0.8114
InvestorGary S Jacob owns 3,500 units of Common Stock, $0.00001 par value which is worth $2,839.90. In the year 2021 Gary S Jacob filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 7
| |||
Form 4
|
∞
| 3.5K |
$6.79 | $23,761.50 | 3.5K |
Feb 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Hepion Pharmaceuticals, Inc. (HEPA) Snapshot price: $0.7771
CEO and PresidentGary S Jacob owns 32,935 units of Common Stock, par value $0.0001 per share which is worth $25,593.79 and 12,059 units of Common Stock which is worth $9,371.05. From 2013 to 2024 Gary S Jacob acquired a total of 44,935 shares in Hepion Pharmaceuticals, Inc. at a cost of $19,920.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +20,338.98% | 12K |
$1.66 | $19,920.00 | 12.06K |
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 4
|
∞
| 32.94K |
—
|
—
| 32.94K |
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TrovaGene Inc. (CRDF) Snapshot price: $2.3
InvestorGary S Jacob owns 21,922 units of Common Stock which is worth $50,420.60. In the year 2012 Gary S Jacob filed a total of 18 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +12.12% | 2.37K |
$10.42 | $24,689.35 | 21.92K |
Mar 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +845.00% | 17.48K |
$1.43 | $25,000.69 | 19.55K |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +12.60% | 16.67K |
—
|
—
| 148.95K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
| +7.55% | 9.29K |
—
|
—
| 132.29K |
Sep 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OKYO Pharma Ltd (OKYO) Snapshot price: $1.06
Chief Executive OfficerGary S Jacob owns 12,500 units of American Depositary Shares which is worth $13,250.00. In the year 2022 Gary S Jacob filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 12.5K |
$4.00 | $50,000.00 | 12.5K |
May 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||